| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/21/2004 | CN1146411C Use of 1,3-propanediol derivatives |
| 04/21/2004 | CA2463439A1 A delivery system |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723833 Improved polypeptides, including antibodies, which not only don't exhibit the ?deactivating? event of aspartyl isomerization, but also display equal to or better than affinity to the target molecule (e.g., antigen) |
| 04/20/2004 | US6723832 Isolated peptides corresponding to amino acid sequences of NY-ESO-1, which bind to MHC Class I and MHC Class II molecules, and uses thereof |
| 04/20/2004 | US6723831 Removal antibodies from body fluids |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723558 Comprise mixtures of 10,000 different recombinant viruses that each express a different hiv env variant containing both constant and variable regions; used as vaccines; envelop proteins (env) |
| 04/20/2004 | US6723556 Nucleic acid encoding a fragment of bovine luteinizing hormone/chorionic gonadotropin receptor |
| 04/20/2004 | US6723535 Nucleotide sequences coding polypeptides for use in the diagnosis, treatment and prevention of cancer, skin, vascular, kidney and inflammatory disorders |
| 04/20/2004 | US6723518 Diagnosing mammary gland pathologies; obtain biopsies, screen for expression of chemokines, presence of chemokine indicates pathology |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723329 Administering an effective amount of a b2l viral envelope protein of a parapox virus and an antigen to enhance immune response |
| 04/20/2004 | US6723328 A homogenized, killed pure microsporum canis culture provided in a carrier wherein the culture is isolated by filtration. |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | US6723325 Attenuated vaccinia viruses that can be used in vaccination methods against variola virus |
| 04/20/2004 | US6723324 Chicken anaemia viruses of low pathogenicity |
| 04/20/2004 | US6723323 Vibrio Cholerae vaccine candidates and method of their constructing |
| 04/20/2004 | US6723319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies |
| 04/20/2004 | US6723318 Targeting of biomolecules |
| 04/20/2004 | US6723317 Binds to amino acid sequence 1,2 or 4; identification of human papillomavirus (hpv) 16 viral structures |
| 04/20/2004 | US6722062 Capsular polysaccharides from enterococci |
| 04/20/2004 | CA2248182C Porcine reproductive and respiratory syndrome vaccine |
| 04/20/2004 | CA2067916C Method for detecting inflammation |
| 04/20/2004 | CA2057792C Process for immobilization onto the surfaces of elisa plates of a compound carrier complex and for immunization |
| 04/15/2004 | WO2004031775A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031774A2 Method for treating or preventing metastasis of colorectal cancers |
| 04/15/2004 | WO2004031767A2 Prevention of primary sjögren’s syndrome by ica69 deficiency |
| 04/15/2004 | WO2004031409A2 Method for diagnosing chronic myeloid leukemia |
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031390A1 Vector system |
| 04/15/2004 | WO2004031365A2 Sulfatases and methods of use thereof |
| 04/15/2004 | WO2004031361A2 Three-dimensional peripheral lymphoid organ cell cultures |
| 04/15/2004 | WO2004031360A2 Therapeutic aptamers having binding specificity to gp41 of hiv |
| 04/15/2004 | WO2004031358A2 Genetically engineered p30 antigen, improved antigen cocktail, and uses thereof |
| 04/15/2004 | WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 04/15/2004 | WO2004031345A2 Cytotoxic t-cell epitopes of hiv-1 virus |
| 04/15/2004 | WO2004031237A1 Genes and polypeptides relating to human myeloid leukemia |
| 04/15/2004 | WO2004031236A2 Therapeutic uspa1-derived peptides |
| 04/15/2004 | WO2004031230A2 Novel mhc ii associated peptides |
| 04/15/2004 | WO2004031226A1 Immunogenic library of chimeric peptides mimicking the genetic diversity of the hypervariable region v3 of the protein of the envelope of a virus gp 120 of human immunodeficiency |
| 04/15/2004 | WO2004031224A2 Hbv mutations associated with reduced susceptibility to adefovir |
| 04/15/2004 | WO2004031222A2 Dna vaccine encoding at least two nonstructural early proteins of papillomavirus |
| 04/15/2004 | WO2004031217A1 Vaccines of enhanced immunogenicity, and methods for preparing such vaccines |
| 04/15/2004 | WO2004031212A1 Antigenic peptides |
| 04/15/2004 | WO2004031211A2 Hla binding peptides and their uses |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031105A2 Use of a33 antigens and jam-it |
| 04/15/2004 | WO2004030701A1 Conjugated hydroxyalkyl starch allergen compounds |
| 04/15/2004 | WO2004030697A1 Use of protein tyrosine phosphatase inhibitors for prevention and/or treatment of cancer |
| 04/15/2004 | WO2004030696A2 Composition for vaccination |
| 04/15/2004 | WO2004030694A1 Bacteriophage-mediated immunisation against hepatitis |
| 04/15/2004 | WO2004030685A2 Use of il-2 receptor antibodies to prevent toxicity associated with amphotericin b antimycotic therapy |
| 04/15/2004 | WO2004030636A2 Human papillomavirus polypeptides and immunogenic compositions |
| 04/15/2004 | WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same |
| 04/15/2004 | WO2004030614A2 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor |
| 04/15/2004 | WO2004030613A2 Cancer therapy using beta glucan and antibodies |
| 04/15/2004 | WO2004030608A2 Nanoemulsion vaccines |
| 04/15/2004 | WO2004030522A2 Diagnosis and monitoring of diseases |
| 04/15/2004 | WO2004030519A2 Thymic atrophy |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004011486A3 Method for solubilizing hydrophobic peptides and use thereof for inducing an antitumoral and/or anti-infectious ctl response |
| 04/15/2004 | WO2004007552A8 Cytokine receptor |
| 04/15/2004 | WO2004000351A1 Packaged virus-like particles for use as adjuvants: method of preparation and use |
| 04/15/2004 | WO2003102144A3 Compositions and methods of use for an ephrin rreceptor |
| 04/15/2004 | WO2003094849A3 Ferritin fusion proteins for use in vaccines and other applications |
| 04/15/2004 | WO2003094846A3 Intrathecal and intratumoral superantigens to treat malignant disease |
| 04/15/2004 | WO2003085134A3 Methods of diagnosing and treating colorectal cancer |
| 04/15/2004 | WO2003076646A3 Identification and tissue distribution of two novel spliced variants of the mouse lats2 gene |
| 04/15/2004 | WO2003072602A3 Protein complexes and methods for their use |
| 04/15/2004 | WO2003070752A3 Mhc-peptide complex binding ligands |
| 04/15/2004 | WO2003068151A3 Human antibodies for therapy against vaccinia or smallpox |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003065010B1 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis |
| 04/15/2004 | WO2003061555A3 West nile vaccine |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003054212A8 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 04/15/2004 | WO2003020767A9 Antibodies against caspase-8, their preparation and use |
| 04/15/2004 | WO2003008571A9 Chimeric chains that code for proteins that induce effects directed against viruses |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002102975A3 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | US20040073016 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040073007 Antiangiogenic peptides |
| 04/15/2004 | US20040073006 Antibody against norwalk virus and method of detecting virus by using the antibody |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072787 Cancer |
| 04/15/2004 | US20040072781 Materials and methods relating to fusion proteins an immune response |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072753 Peptides for use in the treatment of alzheimer's disease |